-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
-
Tech firms gain ahead of Fed decision, results from AI giants
-
Floriani hits maiden goal as Lazio go top
-
Syria condemns deadly Jordan strikes as 'unacceptable violation'
-
Trump set to drastically loosen oil and gas sector's methane rules
-
England's Fin Smith in race against time to face Australia
-
Storied Paris department store seeks bankruptcy protection
-
UN nuclear watchdog chief urges Iran to grant access
-
Xhaka, Embolo can return to Swiss squad after fake Covid docs affair
-
Boeing shares tumble after it releases cautious growth forecast
-
Allegri suspended for two Serie A games after red card
-
Lula's re-election revives Brazil-US tensions
-
Flight data, satellite images reveal growing US role at Ecuador base
-
Carney moves to remake Canada alliances as US ties strained
-
McInnes feels 'guilt' ahead of Hearts return with Rangers
-
Serbia's students demand state media chiefs resign after poll win
-
Brazil's Lula turns 81, vows to work '24 hours a day'
-
Starc takes six as Australia fight back in South Africa decider
-
Boeing releases cautious growth plan as shares fall sharply
-
UK man offered drugged wife to strangers online for sex: court
-
Exiled Russian dissident Navalnaya warns dictators becoming 'more cunning'
-
Africa Ebola outbreak passes 10,000 cases, mostly in DR Congo
-
Bayern 'risk' reaps huge reward for Ballon d'Or winner Kane
-
EU pushes for more nations to pay to protect nature
-
Record turnout as Israeli voters deliver verdict on Netanyahu
-
Boeing reports smaller loss as it aims for stable output growth
-
Iraola says Isak 'feels the trust' after Liverpool scoring streak
-
Tech firms gain on Anthropic IPO optimism; HSBC slumps in London
-
French media protest manhandling of journalists at far-right party rally
-
Sri Lanka end England hopes with crushing win over Pakistan
-
EU seeks deportation powers for beefed up border agency
-
Dangote, Nigeria's oil tycoon rewriting Africa's story
-
Two charged with UK security offences over airbase plot: police
-
Carrick to remain Man Utd boss for Chelsea clash: reports
-
Maresca defends Donnarumma, Guehi after Man City defeat
-
Greenhouse gas levels hit new record highs in 2025: UN
-
Nordic leaders call Putin as local truce begins in Ukraine
-
Rybakina looking to clinch year-end number one in Tokyo
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
- Video webcasts to be available on-demand Tuesday, July 22nd
FRENCHTOWN, NJ / ACCESS Newswire / July 18, 2025 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the participating company line up for the Virtual Investor "What's Your Story" Summer Spotlight. On-demand presentations will be available beginning Tuesday, July 22, 2025.
For the event, management from the participating companies will dive deeper into their dedication to their respective companies, how they got to where they are today and provide insight into why they are so passionate about the products and programs in development.
The participating companies include:
Akari Therapeutics, Plc (NASDAQ: AKTX)
Autonomix Medical, Inc. (NASDAQ: AMIX)
AIM ImmunoTech, Inc. (NYSE American: AIM)
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)
enVVeno Medical Corporation (NASDAQ: NVNO)
Exxel Pharma (Private)
GRI Bio, Inc. (NASDAQ: GRI)
iTolerance, Inc. (Private)
Kaida BioPharma (Private)
Moleculin Biotech, Inc. (NASDAQ: MBRX)
Nuwellis, Inc. (NASDAQ: NUWE)
Outlook Therapeutics, Inc. (NASDAQ: OTLK)
Palisade Bio, Inc. (NASDAQ: PALI)
Senti Biosciences, Inc. (NASDAQ: SNTI)
All investors and interested parties will be able to access the list of participating companies at virtualinvestorco.com. The on-demand presentations will be available on the Virtual Investor website, as well as the Investor sections of the respective company websites.
To access all Virtual Investor events, visit www.virtualinvestorco.com.
JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies' websites and the SEC website for the latest information and filings on each company.
About JTC Team
JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.
Contact:
Jenene Thomas
JTC Team, LLC
T: +1 (908) 824-0775
[email protected]
SOURCE: JTC Team, LLC
View the original press release on ACCESS Newswire
R.Garcia--AT